Robert Waltermire
Net worth: 3 M $ as of 30/07/2026
Net worth: 3 M $ as of 30/07/2026
Robert Waltermire is currently the Chief Pharmaceutical Development Officer at Madrigal Pharmaceuticals, Inc. He previously worked at Venatorx Pharmaceuticals, Inc. as the Senior Vice President-CMC from 1988 to 2020.
Waltermire completed his undergraduate degree at Franklin & Marshall College in 1984 and obtained his doctorate from the University of Maryland in 1988.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/03/2025 | 5,789 ( 0.03% ) | 3 M $ | 30/07/2026 |
| Companies | Position | Start |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2021 |
| Companies | Position | End |
|---|---|---|
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel anti-infectives to treat multi-drug-resistant bacterial and viral infections | Corporate Officer/Principal | 31/12/2019 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel anti-infectives to treat multi-drug-resistant bacterial and viral infections | Health Technology |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions